Manufacturer
L.B.S. LABS LTD PART
Contents
Medroxyprogesterone acetate
Indication
Endometriosis, Contraception, Palliative treatment of endometrial and renal carcinoma, Palliative treatment of prostatic carcinoma, Breast cancer.
Instruction
Administer via Subcutaneous/IM Injection.
Drug interaction
Aminoglutethimide and enzyme-inducing drugs (e.g. carbamazepine, griseofulvin, phenobarbital, rifampicin, phenytoin) may reduce plasma concentrations leading to reduced efficacy. Additional measures required when medroxyprogesterone is used for contraception during coadministration with these drugs.
L.B.S. LABS LTD PART
Contents
Medroxyprogesterone acetate
Indication
Endometriosis, Contraception, Palliative treatment of endometrial and renal carcinoma, Palliative treatment of prostatic carcinoma, Breast cancer.
Instruction
Administer via Subcutaneous/IM Injection.
Drug interaction
Aminoglutethimide and enzyme-inducing drugs (e.g. carbamazepine, griseofulvin, phenobarbital, rifampicin, phenytoin) may reduce plasma concentrations leading to reduced efficacy. Additional measures required when medroxyprogesterone is used for contraception during coadministration with these drugs.
Inquiry - Non-Preg Injection